Hypertriglyceridemia in experimental diabetes: relationship to cardiac dysfunction.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Canadian Journal of Physiology and Pharmacology

• Publication date

  1994-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1139/Y94-065PMID 7954071
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Changes in peripheral nerves of rats four months after induction of streptozotocin diabetes

  2004cited by this paper
• The effects of prazosin and propranolol in combination with thiazide diuretics on blood pressure and serum lipids: a multicentre study

  2004cited by this paper
• Ascorbic acid supplementation prevents hyperlipidemia and improves myocardial performance in streptozotocin-diabetic rats.

  1995cited by this paper
• Acute diabetes does not reduce heparin-releasable lipoprotein lipase activity in perfused hearts from Wistar-Kyoto rats.

  1993cited by this paper
• The diabetic heart: metabolic causes for the development of a cardiomyopathy.

  1992cited by this paper
• Therapeutic management of triglycerides: an international perspective.

  1992cited by this paper
• Regulation of lipoprotein lipase activity in cardiac myocytes from control and diabetic rat hearts by plasma lipids.

  1992cited by this paper
• Hyperlipidaemia in diabetes.

  1990cited by this paper
• Glucose oxidation rates in fatty acid-perfused isolated working hearts from diabetic rats.

  1989cited by this paper
• Effect of prazosin treatment on carbohydrate and lipoprotein metabolism in patients with hypertension.

  1989cited by this paper
• Effect of L-Carnitine Treatment on Lipid Metabolism and Cardiac Performance in Chronically Diabetic Rats

  1988cited by this paper
• Beneficial Effects of Verapamil in Diabetic Cardiomyopathy

  1988cited by this paper
• Mechanism of direct cardiostimulating actions of hydralazine.

  1987cited by this paper
• Effects of Calcium Antagonists on Glucose Homeostasis and Serum Lipids in Non-Diabetic and Diabetic Subjects: A Review

  1987cited by this paper
• Reduction in Cardiovascular Risk Factors With Intensive Diabetes Treatment in Insulin-Dependent Diabetes Mellitus

  1987cited by this paper
• Myocardial performance and metabolism in non-ketotic, diabetic rat hearts: myocardial function and metabolism in vivo and in the isolated perfused heart under the influence of insulin and octanoate

  1986cited by this paper
• Cardiac function in spontaneously hypertensive diabetic rats.

  1986cited by this paper
• Correlation between effects of hydralazine on force and on the adenyl cyclase system of ventricular myocardium in dogs and cats.

  1986cited by this paper
• Pyruvate attenuation of hypoxia damage in isolated working guinea-pig heart.

  1986cited by this paper
• Effects of hydralazine on streptozotocin-induced diabetic rats: prevention of hyperlipidemia and improvement in cardiac function.

  1986cited by this paper
• The role of calmodulin in hormone-stimulated lipolysis.

  1985cited by this paper
• Diabetic cardiomyopathy.

  1985cited by this paper
• Ultrastructure of heart muscle in short-term diabetic rats: influence of insulin treatment

  1984cited by this paper
• Comparison of in vitro and in vivo effects of prazosin on lipid metabolism.

  1984cited by this paper
• The Role of Circulating Glucose and Triglyceride Concentrations and Their Interactions with Other “Risk Factors” as Determinants of Arterial Disease in Nine Diabetic Population Samples from the WHO Multinational Study

  1983cited by this paper
• Effects of chronic administration of vanadate on blood pressure, heart rate and Na+/K+-ATPase activity in adult male wistar rats.

  1983cited by this paper
• Effects of chronic administration of vanadate on blood pressure, heart rate and Na+/K+-ATPase activity in adult male wistar rats.

  1983cited by this paper
• Endogenous triacylglycerol metabolism in diabetic heart.

  1982cited by this paper
• Prazosin Lowers Plasma Triglyceride Concentration in Rats: A Preliminary Report

  1982cited by this paper
• The effect of chronic alloxan- and streptozotocin-induced diabetes on isolated rat heart performance.

  1982cited by this paper
• Influence of nicotinic acid on metabolism of cholesterol and triglycerides in man.

  1981cited by this paper
• Altered Myocardial Mechanics in Diabetic Rats

  1980cited by this paper
• The Effect of Diabetes on Performance and Metabolism of Rat Hearts

  1980cited by this paper
• Effects of diuretics on plasma lipoproteins in healthy men

  1980cited by this paper
• Cardiac performance of isolated perfused hearts from alloxan diabetic rats.

  1979cited by this paper
• Myocardial dysfunction without coronary artery disease in diabetic renal failure.

  1979cited by this paper
• Diabetes and cardiovascular disease. The Framingham study.

  1979cited by this paper
• Effects of dichloroacetate on the metabolism of glucose, pyruvate, acetate, 3-hydroxybutyrate and palmitate in rat diaphragm and heart muscle in vitro and on extraction of glucose, lactate, pyruvate and free fatty acids by dog heart in vivo.

  1973cited by this paper
• The changes in concentration of cholesterol in the serum of hypertensive patients during antihypertensive therapy.

  1958cited by this paper

• Acute effect of antidiabetic 1,4‐dihydropyridine compound cerebrocrast on cardiac function and glucose metabolism in the isolated, perfused normal rat heart

  2008cites this paper
• Metabolic effects of antihypertensive agents: role of sympathoadrenal and renin-angiotensin systems

  2006cites this paper
• N-acetylcysteine Prevents Nitrosative Stress-Associated Depression of Blood Pressure and Heart Rate in Streptozotocin Diabetic Rats

  2006cites this paper
• Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice.

  2003cites this paper
• Pharmacotherapeutics of Diabetic Cardiomyopathy

  2003cites this paper
• Working heart function in diabetes is not improved by spironolactone treatment.

  2003cites this paper
• Heart metabolic disturbances in cardiovascular diseases.

  2003cites this paper
• Molecular and genetic aspects of cardiac fatty acid homeostasis in health and disease.

  2002cites this paper
• Effect of hypertension on the development of diabetic cardiomyopathy.

  2000cites this paper
• Early manifestations of nephropathy in alloxan-treated rats.

  1998cites this paper
• Metabolic disturbances in diabetic cardiomyopathy

  1998cites this paper
• Strain differences in susceptibility to streptozotocin-induced diabetes: effects on hypertriglyceridemia and cardiomyopathy.

  1997cites this paper
• Effects of vanadium compounds on diabetes induced changes in STZ-diabetic rats

  1996cites this paper
• Therapeutic Interventions in the Diabetic Heart

  1996cites this paper
• Interventions in Experimentally Induced Diabetic Cardiomyopathy

  1996cites this paper
• Role of elevated lipids in diabetic cardiomyopathy.

  1996cites this paper
• Myocardial substrate metabolism: implications for diabetic cardiomyopathy.

  1995cites this paper
• Ascorbic acid supplementation prevents hyperlipidemia and improves myocardial performance in streptozotocin-diabetic rats.

  1995cites this paper
• Improvement in cardiac function in streptozotocin-diabetic rats by salt loading.

  1994cites this paper